The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?

被引：1

作者：

Bautista, Jimmy M.

机构：

[1] Univ Santo Tomas Hosp, Gastroenterol Sect, Manila, Philippines

[2] Quirino Mem Med Ctr, Dept Med, Quezon City, Philippines

[3] Jose R Reyes Mem Med Ctr, Dept Surg, Manila, Philippines

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷

关键词：

D O I：

10.1111/j.1440-1746.2006.04713.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastroesophageal reflux disease is a chronic and relapsing disease. Its symptoms do not correlate well with the degree of reflux events or injury that pose a challenge in its management. Thus far, treatment modalities include lifestyle and dietary modifications, antacids and anti-secretory medications, and anti-reflux surgery. With an erratic symptom atology, high cost of treatment, and fear of complications and side effects, the dilemma arises as to when treatment is stopped. Diverse therapeutic strategies continue to advance to address such concerns. The rising trend of on-demand and intermittent proton pump inhibitor therapy has raised various issues regarding efficacy.

引用

页码：S112 / S114

页数：3

共 50 条

[21] Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor
Oda, K
Iwakiri, R
Hara, M
Watanabe, K
Danjo, A
Shimoda, R
Kikkawa, A
Ootani, A
Sakata, H
Tsunada, S
Fujimoto, K
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1921 - 1926
[22] Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor
Kayoko Oda
Ryuichi Iwakiri
Megumi Hara
Kazuyo Watanabe
Akiko Danjo
Ryo Shimoda
Atsushi Kikkawa
Akifumi Ootani
Hiroyuki Sakata
Seiji Tsunada
Kazuma Fujimoto
Digestive Diseases and Sciences, 2005, 50 : 1921 - 1926
[23] Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy
Shaheen, Nicholas J.
Denison, Hans
Bjorck, Karin
Silberg, Debra G.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04): : 529 - 534
[24] Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy
Sugimoto, Mitsushige
Nishino, Masafumi
Kodaira, Chise
Yamade, Mihoko
Uotani, Takahiro
Ikuma, Mutsuhiro
Umemura, Kazuo
Furuta, Takahisa
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (14) : 1858 - 1865
[25] Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy
Mitsushige Sugimoto
Masafumi Nishino
Chise Kodaira
Mihoko Yamade
Takahiro Uotani
Mutsuhiro Ikuma
Kazuo Umemura
Takahisa Furuta
World Journal of Gastroenterology, 2011, 17 (14) : 1858 - 1865
[26] Economic evaluation of on-demand maintenance therapy with proton pump inhibitors in patients with symptomatic gastroesophageal reflux disease - A Monte-Carlo analysis for Italy
Hughes, DA
Marchetti, M
Colombo, GL
VALUE IN HEALTH, 2004, 7 (06) : 753 - 754
[27] Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan
Nagahara, A.
Asaoka, D.
Hojo, M.
Sasaki, H.
Shimada, Y.
Matsumoto, K.
Ueyama, H.
Shibuya, T.
Sakamoto, N.
Osada, T.
Watanabe, S.
HIPPOKRATIA, 2015, 19 (01) : 53 - 56
[28] What are the precautions with proton pump inhibitor use for reflux disease?
Mospan, Cortney M.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (12): : 23 - 26
[29] The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease
Wasko-Czopnik, Dorota
Wiatrak, Benita
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (01): : 60 - 66
[30] Efficacy of Hangeshashinto on Gastrointestinal Symptoms in Patients With Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitor Therapy
Takeuchi, Toshihisa
Kawaguchi, Shinpei
Takahashi, Yoshiaki
Harada, Satoshi
Ota, Kazuhiro
Kojima, Yuichi
Higuchi, Kazuhide
GASTROENTEROLOGY, 2016, 150 (04) : S478 - S478

← 1 2 3 4 5 →